ESC2 suggests considering prophylaxis for cardiac txp pts w o specifying valvulopathy Pts

By rray, 20 October, 2023
Detail (Long)
<b>ESC</b><sup>2</sup> suggests considering prophylaxis for cardiac txp pts (w/o specifying valvulopathy). Pts <6mo post-op vascular graft, vena cava filter, or CNS ventriculoatrial shunt are also deemed high risk. <b>For intermediate-risk pts,</b> prophylaxis isn’t routine (no evidence), but consider case-by-case: rheumatic heart dz, nonrheumatic degenerative valve dz, abnl congenital valve (e.g., bicuspid aortic), implanted electronic devices, hypertrophic cardiomyopathy.